PharmaBoardroom

Vladimír Velebný – CEO, Contipro, Czech Republic

Vladimír Velebný, founder and CEO, celebrates his 30th anniversary heading Contipro, a mid-sized company with deep experience in R&D…

Krisztina Kárpát – Managing Director & CFO, Bayer…

Krisztina Kárpát, MD of Bayer Hungary, elaborates on the successful development of the affiliate in recent years, making progress in all three…

Sławek Ludwiczuk – Country Head, Bayer Consumer Health…

Sławek Ludwiczuk, country head Bayer Consumer Health Czech Republic & Slovakia, explains how Bayer has successfully adapted to the rapidly…

Judit Bidlo – Deputy Director General of Price Support,…

Judit Bidlo, deputy director general of price support at the Hungarian National Health Insurance (NEAK), shares her insights on the healthcare…

Jiří Volf – General Manager, BB Pharma, Czech Republic

Jiří Volf, GM of BB Pharma, explains his motivation behind starting an entrepreneurial journey, the company’s competitive advantage in the face of…

Ashraf Allam – Regional VP Middle East, Turkey &…

Mundipharma, through its model of independent associated companies, is aiming to take the lead in the Middle East, Turkey & Africa markets through…

Adriana Stara – General Manager, Allergan Central Europe…

Adriana Stara, general manager Central Europe & Baltics at Allergan, explains how her previous experiences have prepared her to drive Allergan’s…

Martina Stenerdal – General Manager, PPD Scandinavia

As a worldwide research powerhouse, Sweden is benefiting from the presence of multinational clinical research organizations like PPD. Martina…

Bernard Bauer – CEO & Board Member, German-Czech…

Bernard Bauer, CEO and board member at the German-Czech Chamber of Industry and Commerce, discusses the factors that make the German-Czech…

Value-Based Healthcare in Hungary: Exploring the Possibilities

Among the efforts of Hungarian stakeholders to determine more efficient pricing and reimbursement structures, there is a common ambition to explore…

Hungary: Entering a New Age of Patient Access?

In 2016, Hungary transitioned from a second-tier member to a full member of the EU. As Judit Bidló, deputy director general of pricing and…

Problems Pile Up at Ipsen after Further Clinical Setback

These are worrying times for iconic French mid-cap Ipsen. Trials for palovarotene, a treatment for rare bone disorders, have been plagued by setbacks,…

Tagged with